# US 2020/0138734 A1 · Topical formulation for treating bruising

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0138734 A1
- Document ID: US20200138734A1
- Status: Published application
- Kind: A1
- Application number: 16/728,329
- Filed: 2019-12-27
- Published: 2020-05-07
- Earliest claimed: 2018-07-23
- Inventors: Jerry McSHANE
- Web page: https://patentgrep.com/patent/US20200138734A1

## CPC

- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A topical formulation for treating bruising can include a protein denaturant, preferably 2-butanol, a penetration enhancer, preferably a combination of dimethyl isosorbide and propylene glycol, and water. The topical formulation can be particularly effective for reversing bruising caused by Senile Purpura and/or preventing hemosiderin staining.

## Claims

### Claim 1

A topical formulation for treating bruising, the formulation comprising a protein denaturant, a penetration enhancer, a preservative, and water.

### Claim 2 (depends on 1)

The topical formulation for treating bruising according to claim 1, wherein the protein denaturant is 2-Butanol and the penetration enhancer is dimethyl isosorbide and propylene glycol.

### Claim 3 (depends on 2)

The topical formulation for treating bruising according to claim 2, wherein the 2-Butanol is 4-12% weight of the formulation, the dimethyl isosorbide is 20-40% and the propylene glycol is 1-10%.

### Claim 4 (depends on 3)

The topical formulation for treating bruising according to claim 3, wherein the 2-Butanol is 10% weight of the formulation, the dimethyl isosorbide is 30% and the propylene glycol is 5%.

### Claim 5

A topical formulation for treating bruising, the formulation comprising poloxamer 407, dimethyl isosorbide, 2-Butanol, propylene glycol, Sodium Chloride, Germall® Plus, and water.

### Claim 6

A topical formulation for treating bruising, comprising the formulation by % weight:
Poloxamer 407
16-19
Dimethyl isosorbide
20-40
2-Butanol
4-12
Propylene glycol
1-10
Sodium Chloride
0.1-0.5
Germall ® Plus
0.1-0.5
Water
Balance

### Claim 7 (depends on 6)

The topical formulation for treating bruising according to claim 6, wherein the formulation includes dimethyl isosorbide at 30%, 2-Butanol at 10%, and propylene glycol at 5%.

### Claim 8 (depends on 6)

The topical formulation for treating bruising according to claim 6, wherein the formulation includes dimethyl isosorbide at 30%.

### Claim 9 (depends on 6)

The topical formulation for treating bruising according to claim 6, wherein the formulation includes 2-Butanol at 10%.

### Claim 10 (depends on 6)

The topical formulation for treating bruising according to claim 6, wherein the formulation includes propylene glycol at 5%.

### Claim 11 (depends on 6)

The topical formulation for treating bruising according to claim 6, wherein the formulation is in a topical administration form selected from the group consisting of an ointment, a ointment cream, a lotion, a thermogallin liquid, a roll-on, a patch, a gel, a paste, a micelle, a dermal patch, or an occlusion.

### Claim 12 (depends on 6)

A method of treating bruising, comprising administering the topical formulation of claim 6 to a patient in need thereof.
